Pure Global

The Effect of Lactobacillus Delbrueckii Subsp. Bulgaricus on Human's Weight Reduction - Trial NCT06244186

Access comprehensive clinical trial information for NCT06244186 through Pure Global AI's free database. This phase not specified trial is sponsored by China Medical University Hospital and is currently Completed. The study focuses on Overweight and Obesity. Target enrollment is 36 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT06244186
Completed
dietary supplement
Trial Details
ClinicalTrials.gov โ€ข NCT06244186
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
The Effect of Lactobacillus Delbrueckii Subsp. Bulgaricus on Human's Weight Reduction

Study Focus

Overweight and Obesity

Probiotics

Interventional

dietary supplement

Sponsor & Location

China Medical University Hospital

Taichung, Taiwan

Timeline & Enrollment

N/A

Sep 10, 2021

Nov 03, 2023

36 participants

Primary Outcome

Body weight,Body fat,BMI

Summary

To evaluate the improvement in weight, body fat, and BMI after adding probiotics as a
 once-daily therapy for 84 days in overweight individuals.

ICD-10 Classifications

Obesity
Other obesity
Obesity due to excess calories
Obesity, unspecified
Obesity and other hyperalimentation

Data Source

ClinicalTrials.gov

NCT06244186

Non-Device Trial